Clinical trials recruiting for Invasive Breast Carcinoma
14
Recruiting trials
48
US states with sites
6
Countries
7%
Accept healthy volunteers
Phase breakdown
Phase 1 2Phase 2 2Phase 3 1Not applicable 9
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 6 |
| Pennsylvania | 6 |
| Texas | 5 |
| Florida | 4 |
| Minnesota | 4 |
| New Jersey | 4 |
| North Carolina | 4 |
| Arizona | 3 |
| Colorado | 3 |
| Massachusetts | 3 |
| Missouri | 3 |
| New York | 3 |
Top cities
Aurora, Colorado 3Houston, Texas 3New York, New York 3Philadelphia, Pennsylvania 3Rochester, Minnesota 3Sacramento, California 3St Louis, Missouri 3Appleton, Wisconsin 2Aventura, Florida 2Baltimore, Maryland 2
Self-screener
Recruiting trials
- A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer
- Application of Single-Port Robot-Assisted Breast-Conserving Surgery Via Axillary Approach for Breast Cancer.
- Breast Cancer Survivorship Biorepository
- Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
- Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial
- Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy
- Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy
- ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer
- Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in IBC
- Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
- Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer
- Time Restricted Eating for the Improvement of Outcomes in Patients With Stage I-III Breast Cancer Receiving Chemotherapy Before Surgery
Related conditions
Trials recruiting for Invasive Breast Carcinoma often also study these conditions. Each links to its own recruiting-trial list.
Breast cancer 2239Anatomic Stage III Breast Cancer AJCC v8 39Anatomic Stage II Breast Cancer AJCC v8 35Anatomic Stage I Breast Cancer AJCC v8 30Anatomic Stage IV Breast Cancer AJCC v8 43Triple Negative Breast Carcinoma 10Stage IV Breast Cancer AJCC v6 and v7 3Pancreatic cancer 870Metastatic Triple-Negative Breast Carcinoma 18Melanoma 487
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Invasive Breast Carcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.